Air Barrier System for the Prevention of Prosthesis-related Infections
Status: | Recruiting |
---|---|
Conditions: | Infectious Disease, Orthopedic |
Therapuetic Areas: | Immunology / Infectious Diseases, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 9/8/2018 |
Start Date: | April 24, 2015 |
End Date: | October 2019 |
Contact: | Sean Self |
Email: | self@nimbicsystems.com |
Phone: | 281-565-5715 |
This is a prospective, randomized, blinded clinical trial to determine if the Air Barrier
System device reduces the incidence of surgical site infection after total hip replacement,
acetabular repair, posterior spinal fusion, and prosthetic vascular graft procedures.
System device reduces the incidence of surgical site infection after total hip replacement,
acetabular repair, posterior spinal fusion, and prosthetic vascular graft procedures.
This project is an evaluation of a novel device, the Air Barrier System (ABS), to reduce the
risk of prosthesis-related surgical site infection in a multi-center clinical trial. The ABS
shields surgical incisions intra-operatively by creating a field of high-purity air
surrounding an incision that prevents airborne microorganisms from entering the incision.
This research will evaluate ABS performance in a prospective, randomized, blinded
multi-center trial. The surgical procedures studied will include total hip arthroplasty,
trauma-related acetabula reconstruction, posterior instrumented spine fusion, and prosthetic
vascular graft procedures. Patients will be enrolled during the first two years of the study,
and CDC guidelines require a one year follow-up period to monitor patients for potential
prosthesis-related infections.
risk of prosthesis-related surgical site infection in a multi-center clinical trial. The ABS
shields surgical incisions intra-operatively by creating a field of high-purity air
surrounding an incision that prevents airborne microorganisms from entering the incision.
This research will evaluate ABS performance in a prospective, randomized, blinded
multi-center trial. The surgical procedures studied will include total hip arthroplasty,
trauma-related acetabula reconstruction, posterior instrumented spine fusion, and prosthetic
vascular graft procedures. Patients will be enrolled during the first two years of the study,
and CDC guidelines require a one year follow-up period to monitor patients for potential
prosthesis-related infections.
Inclusion Criteria:
- Total hip arthroplasty;
- Acetabular repair with instrumentation;
- Posterior lumbar, cervical, or thoracic (up to and including 6 vertebral levels) spine
fusion with instrumentation and vascular prosthetic graft implantation.
Exclusion Criteria:
- History of prior prosthesis infection;
- Active infection;
- Open traumatic wounds as is the case after some acetabular fractures.
We found this trial at
1
site
2002 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
(713) 791-1414
Principal Investigator: Rabih O Darouiche, MD
Phone: 713-794-7127
Michael E. Debakey VA Medical Center The Michael E. DeBakey VA Medical Center serves as...
Click here to add this to my saved trials